DFCI Logo
DFCI Logo

Pharmacy Residency Programs

pharmacy-residents653x447.jpg

Dana-Farber Cancer Institute's Pharmacy department leads programs and practices to ensure safe, optimal, and cost-effective drug therapy for Dana-Farber patients, while also supporting patient and provider drug education and patient care-oriented research. 

Post-Graduate Year 2 (PGY-2) pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY-2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic or other specialized positions, along with board certification, if available.

We are proud to offer the following PGY-2 Pharmacy Residency Programs:

  • Oncology Pharmacy Residency (ONC) – 2 positions (ASHP-accredited)
  • Pain Management/Palliative Care Pharmacy Residency (PMPC) – 1 position (ASHP-accredited)
  • Medication-Use Safety and Policy (MUS) – 1 position (ASHP Candidate status)

Pharmacy Resident Benefits

Pharmacy residents will receive competitive benefits for the PGY-2 residency year: 

  • Holidays: New Year’s Day, Martin Luther King Jr. Birthday Observance, President’s Day, Memorial Day, Juneteenth Observance, Independence Day, Labor Day, Indigenous Peoples' Day, Thanksgiving Day, and Christmas Day are all observed holidays.
  • Vacation Days: Three weeks of vacation time is earned over the course of the year. Vacation days are to be approved by the residency director.
  • Professional Meetings/Professional Days: Residents attend two national meetings, including ASHP Mid-Year Meeting. Conference fee and travel compensation will be provided for required conferences.
  • Sick Days: Residents will earn one sick day per month and may be used in accordance with Dana-Farber policy.
  • Salary and Benefits: The annual resident salary is $60,000. Other benefits include, but are not limited to, health, dental, and prescription benefits, and MBTA discount passes.

Virtual Open House

We will be hosting a virtual open house for our residency programs in Medication Safety, Pain Management and Palliative Care, and Oncology, where you can meet our Residency Program Directors and our current residents and preceptors. Please consider joining to learn more about our residency programs and ask questions! For more information please email Eno Inyang, PharmD, BCPS, BCOP at eno_inyang@dfci.harvard.edu.

  • When: November 15, 2023 6:00-7:30PM ET
  • Where: Zoom
  • How to sign up
  • Registration deadline: November 10, 2023

Contact Oncology PGY-2

Eno Inyang, PharmD, BCPS, BCOP
Clinical Pharmacy Manager – Education and Professional Development
eno_inyang@dfci.harvard.edu

Residency Program Director, Oncology

Eno Inyang, PharmD, BCPS, BCOP
Clinical Pharmacy Manager – Education and Professional Development
Clinical Pharmacy Specialist, BMT
Education: University of Southern California, Los Angeles, CA
PGY-1: St. Joseph Medical Center, Tacoma, WA
PGY-2 Oncology: Dana-Farber Cancer Institute, Oncology
Precepts: Ambulatory Hematopoietic Stem Cell Transplant, Inpatient Malignant Hematology

About Our Pharmacy Residency Programs

Oncology Pharmacy Residency (ONC)

The Dana-Farber Cancer Institute (DFCI) PGY-2 Oncology Pharmacy Residency is a 12-month postgraduate educational and training experience designed to develop advanced knowledge, skills, and leadership in the delivery of pharmaceutical services to patients with cancer. Residents who successfully complete a PGY-2 oncology pharmacy residency at Dana-Farber will be prepared to become proficient and board-certified clinical oncology pharmacy practitioners, educators, and leaders.

Residents in the Oncology Pharmacy Residency will gain experience in a variety of areas of clinical oncology practice, including inpatient and outpatient adult solid tumor and hematologic malignancies, palliative care, pediatric oncology, ambulatory infusion pharmacy, and investigational drug services. In addition to providing direct patient care, residents are involved in various educational, safety, administrative, and research projects.

Outcomes

The DFCI PGY-2 Oncology Pharmacy Residency is constructed to develop the resident’s knowledge and experience in various areas of oncology pharmaceutical care, therapeutics, academia, and other areas of oncology pharmacy to acquire the skills necessary for practicing at the top of their license. Residents completing the DFCI PGY-2 Oncology Pharmacy Residency will have developed their clinical, leadership and research skills, time management, interpersonal communication and teaching approach. Upon completion of the residency, the resident will be prepared and well qualified to enter into various fields of clinical oncology pharmacy practice. The resident is expected to provide accurate, professional, detailed and quality driven services for each task they complete. The resident will be held accountable for participation in their own professional development including professional presentations and teaching experiences in addition to developing their long-term career goals.

Through these educational experiences, residents will:

  • Provide evidence-based and patient-centered care to oncology patients within interdisciplinary teams.
  • Develop various teaching styles for application in a variety of settings, including experiential education, small group teaching, and formal presentation.
  • Refine communication and time management skills.
  • Conduct a year-long, publishable oncology-related research or quality improvement project.
  • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

Oncology Pharmacy Learning Experiences

Core Clinical Learning Experiences

  • Orientation (2 weeks)
  • Palliative Care (inpatient, 2 weeks)
  • Malignant Hematology (inpatient, 5 weeks)
  • Lymphoma (ambulatory, 4 weeks)
  • Multiple Myeloma (ambulatory, 4 weeks)
  • Genitourinary/Thoracic Oncology (ambulatory, 4 weeks)
  • Breast Oncology (ambulatory, 4 weeks)
  • Hematopoietic Stem Cell Transplant (HSCT) (inpatient, 4 weeks)
  • Pediatric Oncology (ambulatory, 4 weeks)

Longitudinal Learning Experiences

  • Medication safety (2 months)
  • Oncology pharmacy administration (11 months)
  • Oncology topic discussions (12 months)
  • Academia (10 months)
  • Research/Quality Improvement project (12 months)
  • Oncology infusion pharmacy (ambulatory, 12 months)
  • Investigational drug services (ambulatory, 2 months)

Elective Learning Experiences

Four weeks of the year are dedicated to an elective based on resident interest. They may choose to repeat a core rotation (listed below) or pursue a different area of interest.

  • Immune Effector Cell Therapy (ambulatory) 
  • Hematopoietic Stem Cell Transplant (ambulatory)
  • Leukemia (ambulatory)
  • Gastrointestinal Oncology (ambulatory)

Residency Learning Experiences/Educational Activities

Research Project

Research projects will be determined according to the resident's interest and departmental needs. The resident is required to complete one project and present a poster at the HOPA (Hematology/Oncology Pharmacy Association) annual conference. Research results will be shared with pharmacists in the Boston area at a roundtable research event sponsored by Dana-Farber. The resident will also prepare a finished manuscript suitable for publication by the end of the residency year.

Examples of past resident research projects include:

  • Decreasing Costs and Clinic Wait Time While Maintaining Safety for Patients Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) for Multiple Myeloma (accepted Oral Presentation at ASH 2021)
  • Mapping myeloma using clinical pathways: a roadmap of daratumumab use (accepted ASH poster presentation, 2021)
  • Evaluation of infusion reactions in patients receiving daratumumab post-implementation of an augmented pre- and peri-medication regimen (accepted ASH poster presentation, 2018)
  • Evaluation of thromboembolic events in patients receiving direct oral anticoagulation therapy (accepted ASH poster presentation, Dec 2017)

Medication-Use Evaluations (MUEs)

Residents complete a MUE during the first half of the year to present by poster at the ASHP Midyear Meeting. Residents are presented with MUE topics at the start of the residency year and may collaborate on one MUE or choose separate MUEs.

Continuing Education (CE) Programs

Dana-Farber’s Department of Pharmacy is approved by the Accreditation Council for Pharmacy Education (ACPE) to offer continuing education programs for pharmacists and technicians. Residents are required to provide one ACPE-accredited CE presentation during the residency year (Fall, Winter or Spring).

Didactic Lectures

Dana-Farber’s PGY-2 Oncology Pharmacy Residency gives residents opportunities to lecture students at MCPHS University – Boston. Residents are expected to present one lecture (Winter/Spring) for the oncology elective at MCPHS University. Residents may co-present an assigned topic or choose a topic of their choice.

Precepting Experience

Residents are provided with opportunities to co-precept students affiliated with Northeastern School of Pharmacy and MCPHS University during their inpatient Medical Oncology and Palliative Care learning experiences.

Contact Pain Management/Palliative Care PGY-2

Bridget Scullion, PharmD, BCOP
Residency Program Director / Director, Clinical Pharmacy Services
bridget_scullion@dfci.harvard.edu

Residency Program Director, Pain Management/Palliative Care Pharmacy Residency

Bridget Scullion, PharmD, BCOP
Director, Clinical Pharmacy Services
Education: St. Louis College of Pharmacy, St. Louis, MO
Palliative Care Residency: University of Maryland, School of Pharmacy, Baltimore, MD
Precepts: Harvard Interprofessional Palliative Care Fellowship, Residency Project (PMPC), Pharmacy Leadership and Opioid Stewardship

Pain Management/Palliative Care Pharmacy Residency (PMPC)

The Dana-Farber Cancer Institute PGY-2 Pain Management and Palliative Care Pharmacy Residency is designed to provide the resident with opportunities to develop clinical competence in pain management and palliative care in various settings.

The PGY-2 Pain Management and Palliative Care Pharmacy resident will gain experience in the following areas of practice: inpatient and outpatient palliative care, hospice, inpatient and outpatient pain management, and pain management in the primary care setting. Primary rotation sites include: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and MCPHS University.

Didactic and experiential learning is enhanced through the Harvard Interprofessional Palliative Care Fellowship Program, which provides a nationally rare opportunity for a pharmacy resident to join a fellowship with physician and nurse practitioner fellows in both adult and pediatric palliative care. The pharmacy resident is fully integrated into this fellowship program, which offers didactic and experiential learning geared toward the health care professional working with an interdisciplinary team. There are also opportunities to work with our pediatric palliative care fellows.

Throughout these experiences a resident completing the program will be able to:

  • Demonstrate development as a role model for clinical pharmacists in the pain management and palliative care setting.
  • Develop various teaching styles and approaches for application in a variety of settings, including experiential education, small group teaching, and group lecture.
  • Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
  • Develop skills in the areas of pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
  • Refine communication and time management skills.
  • Develop, implement and analyze data of a yearlong, publishable research or quality project.
  • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

Pain Management/Palliative Care Learning Experiences

Core Clinical Learning Experiences

  • Orientation (2 weeks)
  • Intensive Palliative Care Unit (6 weeks)
  • Hospice I and II (6 weeks: 4 weeks in Fall followed by 2 weeks in Spring)
  • Palliative Care Consult Service (6 weeks)
  • Chronic pain management (12 weeks)
  • Academia (12 weeks concurrent with Ambulatory Pain Management)
  • Post-Operative Pain Service (2 weeks)

Longitudinal Learning Experiences

  • Palliative Care Clinic
  • Harvard Interprofessional Palliative Care Fellowship
  • Quality Improvement/Research Project
  • Outpatient Pharmacy Department
  • Opioid Stewardship

Elective Learning Experience Opportunities

  • Palliative Care Clinic II
  • Hospice III
  • Palliative Care Consult Service II
  • Intensive Palliative Care Unit II
  • Chronic Pain Management II

Contact Medication-Use Safety & Policy PGY-2

Andrew Stivers, PharmD
Residency Program Director/Director of Medication Safety, Quality, and Regulatory Compliance
andrewp_stivers@dfci.harvard.edu
 

Residency Program Director, Medication-Use Safety & Policy

Andrew Stivers, PharmD
Director of Medication Safety, Quality, and Regulatory Compliance
Education: University at Buffalo School of Pharmacy, Buffalo, NY
PGY-1 Training: Riverside Methodist Hospital, Columbus, OH
PGY-2 Medication Use and Safety Training: The Johns Hopkins Hospital, Baltimore, MD
Precepts: Leadership & Patient Safety; Regulatory & Accreditation

Medication-Use Safety and Policy (MUS)

The PGY2 Medication-Use Safety and Policy Residency is a structured 12-month PGY2 residency program that provides advanced training in medication safety, medication-use policy, regulatory and accreditation standards, and quality improvement. Residents completing the program will be well prepared to assume roles including: those with responsibility for developing and implementing system changes that improve the safety within the medication-use system; managing medication-use guidelines and policies; and overseeing regulatory and accreditation compliance.

The resident will work closely with members of Medication Safety, Quality, and Regulatory team to investigate medication errors and near misses, develop and implement system changes to ensure safe and efficient use of medications, assess compliance with regulatory standards, and evaluate medication-use policies and guidelines to ensure alignment with evidence-based best practice recommendations. The resident will learn about the operations of a cancer center through required learning experiences, participation in formal education programs, administrative projects, and staffing in the ambulatory infusion pharmacy.

Over the course of the residency year, residents will:

  • Utilize different risk identification methods to analyze complex systems and implement changes to improve the medication-use system
  • Complete a research or quality improvement project
  • Deliver an ACPE-accredited continuing education program with a focus in medication-use safety
  • Learn and apply methods to promote a culture of safety
  • Participate in the application of technologies that improve the medication-use process
  • Participate and lead committees promoting medication safety

Core Clinical Learning Experiences

  • Orientation
  • Medication Safety Foundations
  • Infusion Operations
  • Informatics and Analytics
  • Opioid Stewardship
  • Accreditation and Regulatory Compliance
  • Advanced Medication Safety

Longitudinal Learning Experiences

  • Drug Information and Education
  • Practice Management
  • Infusion Pharmacy Staffing
  • Quality Improvement
  • Residency Project

Elective Learning Experiences

  • Academia
  • Clinical Oncology
  • Institute for Safe Practices (ISMP) Rotation
  • Outpatient and Specialty Pharmacy Accreditation
  • Oral Anticancer Education
  • Pharmacy Supply Chain

Applying for Pharmacy Residency

Eligibility

Interested applicants must have a PharmD degree and successfully complete an ASHP-accredited PGY-1 pharmacy residency prior to anticipated start date. Candidate must also be eligible for licensure in the Commonwealth of Massachusetts.

Application Procedure

Please submit your application through PhORCAS (Pharmacy Online Residency Centralized Application Service) — portal.phorcas.org — including:

  • Letter of intent
  • Curriculum vitae
  • Three letters of recommendation

Application Deadlines

Oncology: January 5, 2024
Pain Management/Palliative Care and Medication-Use Safety: January 5, 2024
Medication Use Safety and Policy: January 5, 2024
Residency start date: First week in July

Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups, as protected by law.

    Preceptors

    Preceptors

    Oncology

    Meet our Oncology preceptors.

    Gayle C. Blouin, PharmD, BCOP
    Clinical Pharmacy Manager, Satellite Locations
    Education: Northeastern University, Boston, MA (BS Pharm); MCPHS, Boston MA (PharmD)
    PGY-2 Oncology: Dana-Farber Cancer Institute, Boston, MA
    Precepts: Oncology Pharmacy Administration

    Jennifer Espiritu, PharmD, BCOP, CCRP
    Clinical Research Specialist, Investigational Drug Services
    Education: Northeastern University, College of Pharmacy, Boston, MA
    Precepts: Investigational Drug Service

    Mona Hammam, PharmD, MS, BCPS, FISMP
    Medication Safety Officer
    Education: Long Island University, Brooklyn, NY
    Fellowship: Safe Medication Management Fellowship
    Institute of Safe Medication Practices (ISMP), Horsham, PA
    US Food and Drug Administration (FDA), OSE/DMEPA (Office of Surveillance and Epidemiology, Division of Medication Error Prevention and Analysis), White Oak, MD
    Precepts: Medication Safety

    Christy S. Harris, PharmD, BCPS, BCOP
    Associate Professor, MCPHS University, Clinical Pharmacy Specialist
    Education: University of Tennessee Health Sciences, Memphis, TN
    PGY-1: University of Tennessee Medical Center, Knoxville, TN
    PGY-2 Oncology: Medical University of South Carolina, Charleston, SC
    Precepts: Academia

    Shahrier Hossain, PharmD, BCOP 
    Clinical Pharmacy Specialist, Multiple Myeloma
    Education: University at Buffalo, Buffalo, NY
    PGY-1: Albany Medical Center, Albany, NY
    PGY-2: Dana-Farber Cancer Institute, Boston, MA
    Precepts: Myeloma

    Eno Inyang, PharmD, BCPS, BCOP
    Clinical Pharmacy Manager, Education and Professional Development
    Clinical Pharmacy Specialist, BMT
    Education: University of Southern California, Los Angeles, CA
    PGY-1: St. Joseph Medical Center, Tacoma, Washington
    PGY-2 Oncology: Dana-Farber Cancer Institute, Oncology
    Precepts: Ambulatory Hematopoietic Cell Transplant, Inpatient Malignant Hematology

    Chaeyeong Jang, PharmD
    Clinical Pharmacy Specialist – Gastrointestinal Oncology
    Education: University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC
    PGY-1: Pharmacy Residency: Indiana University Health University Hospital, Indianapolis, IN
    PGY-2: Oncology Residency: Indiana University Health Simon Cancer Center, Indianapolis, IN
    Precepts: Ambulatory Gastrointestinal Oncology

    Marina Kaymakcalan, PharmD, BCOP
    Clinical Manager, Oral Antineoplastic Teach; Clinical Pharmacy Specialist, Genitourinary Oncology
    Education: Massachusetts College of Pharmacy and Health Science (MCHPS)
    Precepts: Ambulatory Genitourinary, Oral Antineoplastic Teach

    Houry Leblebjian, PharmD, BCOP
    Manager, Clinical Pharmacy Practice; Clinical Pharmacy Specialist, Myeloma
    Education: Lebanese American University, West Beirut, Lebanon
    PGY-1: UMass Memorial Medical Center, Worcester, MA
    PGY-2 Oncology: Dana-Farber Cancer Institute, Boston, MA
    Precepts: Ambulatory Myeloma, Research

    Patrick McBride, PharmD, BCOP
    Oncology Clinical Pharmacist (Pediatrics)
    PGY-1: Children's Hospital of Wisconsin, Milwaukee, WI
    PGY-2: Dana-Farber Cancer Institute, Boston, MA
    Education: MCPHS University, Boston, MA
    Precepts: Pediatric Oncology

    Emily Messing, PharmD, BCPS
    Medication Safety Officer
    Education: Touro College of Pharmacy, New York, NY
    PGY-1 Training: Montefiore Medical Center, Bronx, NY
    PGY-2 Training: Memorial Sloan Kettering Cancer Center, New York, NY
    Precepts: Medication Safety

    Charles Ni, PharmD, MPH, BCPS, BCOP
    Clinical Pharmacy Specialist – Immune Effector Cell
    Education: The University of Iowa College of Pharmacy, Iowa City, IA (PharmD)
    The University of Iowa College of Public Health, Iowa City, IA (MPH)
    PGY-1: Pharmacy Residency, Rush University Medical Center, Chicago, IL
    Precepts: Ambulatory Immune Effector Cell

    Jian Ni, PharmD, MPH, BCOP
    Oncology Clinical Pharmacy Specialist, Brigham and Women’s Hospital
    Education: Massachusetts College of Pharmacy, Boston, MA (PharmD)
    Columbia University Mailman School of Public Health, New York, NY (MPH)
    PGY-1 Pharmacy Residency: West Virginia University School of Pharmacy, Morgantown, WV
    PGY-2 Oncology Residency: Dana-Farber Cancer Institute, Boston, MA
    Precepts: Inpatient Hematopoietic Cell Transplant 

    Ashka Patel, PharmD, BCOP 
    Clinical Pharmacy Specialist – Lymphoma
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    PGY-1: Beth Israel Deaconess Medical Center, Boston, MA
    PGY-2: Houston Methodist Hospital, Houston, TX
    Precepts: Ambulatory Lymphoma

    Victor Phantumvanit, PharmD, BCPS, BCOP
    Clinical Pharmacy Specialist – Palliative Care
    Education: University of Maryland, School of Pharmacy, Baltimore, MD
    PGY-1: Central Washington Hospital, Wenatchee, WA
    PGY-2 Oncology & Palliative Care: Dana-Farber Cancer Institute, Boston, MA
    Precepts: Inpatient Palliative Care

    Leila Rostamnjad, PharmD, BCOP
    Clinical Pharmacy Manager – Solid Tumors
    Clinical Pharmacy Specialist – Thoracic/Symptom Management
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    PGY-1 Pharmacy Residency: Maine Medical Center, Portland, ME
    PGY-2 Oncology Residency: Rhode Island Hospital, Providence, RI
    Precepts: Ambulatory Thoracic Oncology

    Andrew Skirvin, BS, PharmD, BCOP
    Associate Clinical Professor, Northeastern University, Hematology/Oncology Clinical Pharmacist
    Education: University of Texas Health Science Center (PharmD) and Oregon State University (BS)
    PGY-2 Oncology Specialty Pharmacy: Audie L. Murphy Memorial VA Hospital, San Antonio, TX
    Precepts: Oncology Topic Discussions

    Sydney Smith, PharmD, BCOP
    Clinical Pharmacy Specialist – Collaborative Network / Breast Oncology
    Education: Roseman University of Health Sciences – Henderson, NV
    PGY-1: Cleveland Clinic, Cleveland, OH
    PGY-2: Dana-Farber Cancer Institute, Boston, MA Precepts: Breast Oncology
    Precepts: Breast Oncology

    Loriel Solodokin, PharmD, BCOP
    Assistant Professor, Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Clinical Pharmacy Specialist Hematology/Oncology, Brigham and Women’s Hospital (BWH)/Dana-Farber Cancer Institute (DFCI)
    Education: University of Illinois at Chicago College of Pharmacy
    PGY-1 Pharmacy Residency: NYU Langone Medical Center, New York, NY
    PGY-2 Oncology Residency: The Mount Sinai Hospital, Oncology, New York, NY
    Precepts: Malignant Hematology

    Emily Tiao, PharmD, BCOP
    Clinical Pharmacy Specialist – Leukemia
    Education: Rutgers The State University of New Jersey, New Brunswick, NJ
    PGY-1 Pharmacy Residency: University of Maryland Medical Center, Baltimore, MD
    PGY-2 Oncology Residency: University of Maryland School of Pharmacy, Baltimore, MD
    Precepts: Ambulatory Leukemia
     

    Pain Management/Palliative Care

    Meet our Pain Management/Palliative Care preceptors.

    L. Diana Ardeljan, PharmD, BCPS
    Opioid Stewardship Specialist
    Education: University of Toronto Leslie Dan Faculty of Pharmacy, Toronto, ON
    PGY-1 Pharmacy Residency: Howard County General Hospital, Columbia, MD
    PGY-2 Pain & Palliative Care Residency: The Johns Hopkins Hospital, Baltimore, MD
    Precepts: Opioid Stewardship

    Molly Bacon, PharmD 
    Clinical Pharmacy Specialist - Palliative Care
    PGY-1 Pharmacy Residency: University of Pittsburgh Medical Center- Hamot, Erie, PA
    PGY-2 Pain Management & Palliative Care Residency: Dana-Farber Cancer Institute, Boston, MA
    Education: University at Buffalo, Buffalo, NY
    Precepts: Palliative Care Consult Service I and II

    Minh Do, PharmD
    Outpatient Pharmacy Manager
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Precepts: Outpatient Pharmacy Department

    Benjamin S. Kematick, PharmD, BCACP
    Clinical Pharmacy Specialist - Palliative Care
    PGY-1 Pharmacy Residency: University at Buffalo/Mobile Pharmacy Solutions, Buffalo, NY
    PGY-2 Pain Management & Palliative Care Residency: Dana-Farber Cancer Institute, Boston, MA
    Education: University at Buffalo, Buffalo, NY
    Precepts: Palliative Care Clinic I and II, Quality Improvement/Research

    Michele Matthews, PharmD, CPE, BCACP, FASHP
    Associate Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Advance Practice Pharmacist, Pain Management, Brigham and Women's Hospital, Boston, MA
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    PGY-1 Pharmacy Residency: Robert Wood Johnson Hospital, New Brunswick, NJ
    Precepts: Chronic Pain Management I and II, Academia

    Victor Phantumvanit, PharmD, BCPS, BCOP
    Clinical Pharmacy Specialist - Palliative Care
    Education: University of Maryland, School of Pharmacy, Baltimore, MD
    PGY-1 Pharmacy Residency: Central Washington Hospital, Wenatchee, WA
    PGY-2 Oncology & Palliative Care Residency: Dana-Farber Cancer Institute, Boston, MA
    Precepts: Inpatient Palliative Care Unit I and II

    Alifia Waliji-Banglawala, PharmD
    Director of Pharmacy, Care Dimensions Hospice and Palliative Care, Waltham, MA
    Affiliate Assistant Clinical Professor, Northeastern University Bouvé College of Pharmacy
    PGY-1 Pharmacy Residency: Tampa General Hospital
    Education: University of Florida, Gainesville, FL
    Precepts: Hospice I, II, and III

    Inna Zinger, NP, AGPCNP-BC
    Adult Nurse Practitioner, Post-Operative Pain Service, Brigham and Women's Hospital
    Education: Northeastern University, Boston, MA; MSN, Northeastern University, Boston, MA (BSN)
    Precepts: Post-Operative Pain Service
     

    Medication-Use Safety & Policy

    Meet our Medication-Use Safety & Policy preceptors.

    L. Diana Ardeljan, PharmD, BCPS
    Opioid Stewardship Specialist
    Education: University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, ON
    PGY-1 Pharmacy Residency: Howard County General Hospital, Columbia, MD
    PGY-2 Pain & Palliative Care Residency: The Johns Hopkins Hospital, Baltimore, MD
    Precepts: Opioid Stewardship

    Matt Grissinger, RPh, FISMP, FASCP
    Director, Education at the Institute for Safe Medication Practices
    Education: Philadelphia College of Pharmacy and Science, Philadelphia, PA
    Fellowship: Safe Medication Management Fellowship, Institute of Safe Medication Practices, Horsham, PA
    Precepts: Institute for Safe Medication Practices (ISMP)

    Mona Hammam, PharmD, MS, BCPS, FISMP
    Medication Safety Officer
    Education: Long Island University, Brooklyn, NY
    Fellowship: Safe Medication Management Fellowship
    Institute of Safe Medication Practices (ISMP), Horsham, PA
    US Food and Drug Administration (FDA), OSE/DMEPA (Office of Surveillance and Epidemiology, Division of Medication Error Prevention and Analysis), White Oak, MD
    Precepts: Advanced Medication Safety

    Christy S. Harris, PharmD, BCPS, BCOP
    Associate Professor, MCPHS University, Clinical Pharmacy Specialist
    Education: University of Tennessee Health Sciences, Memphis, TN
    PGY-1 Pharmacy Residency: University of Tennessee Medical Center, Knoxville, TN
    PGY-2 Oncology Residency: Medical University of South Carolina, Charleston, SC
    Precepts: Academia

    Marina Kaymakcalan, PharmD, BCOP
    Clinical Manager, Oral Antineoplastic Teach; Clinical Pharmacy Specialist, Genitourinary Oncology
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Precepts: Oral Anticancer Education

    Juliette Kim, PharmD
    Manager, Materials Management
    Education: Drake University College of Pharmacy & Health Sciences, Des Moines, IA
    PGY-1 Pharmacy Residency: Johns Hopkins Bayview, Baltimore, MD
    PGY-2 Oncology Residency: Yale-New Haven Hospital, New Haven, CT
    Precepts: Materials Management

    Yun Man, PharmD, BCOP
    Medication Use Quality and Policy Specialist
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    PGY-1 Pharmacy Residency: VA Illiana Health Care System
    PGY-2 Oncology Residency: Roswell Park Comprehensive Cancer Center, Buffalo, NY
    Precepts: Quality Improvement

    Emily Messing, PharmD, BCPS
    Medication Safety Officer
    Education: Touro College of Pharmacy, New York, NY
    PGY-1 Pharmacy Residency: Montefiore Medical Center, Bronx, NY
    PGY_2 Medication-Use Safety Residency: Memorial Sloan Kettering Cancer Center, New York, NY
    Precepts: Medication Safety Foundations; Informatics & Analytics

    Andrew Stivers, PharmD
    Director, Medication Safety, Quality, and Regulatory Compliance
    Education: University at Buffalo School of Pharmacy, Buffalo, NY
    PGY-1 Pharmacy Residency: Riverside Methodist Hospital, Columbus, OH
    PGY-2 Medication Use and Safety Residency: The Johns Hopkins Hospital, Baltimore, MD
    Precepts: Orientation, Practice Management; Regulatory & Accreditation

    Olga Vlashyn, PharmD, MS
    Manager, Infusion Pharmacy
    Education: Purdue University College of Pharmacy, West Lafayette, IN
    Combined PGY1/2 MS Health System Pharmacy Administration Residency: Ohio State University Wexner Medical Center, Columbus, OH
    Precepts: Oncology Infusion

    Fuwang Xu, PharmD, BCOP, BCGP
    Manager, Pharmacy Orientation, Training & Competency
    Education: Ohio State University, Columbus, OH
    PGY-1: Northwestern Memorial Hospital, Chicago, IL
    PGY-2 Oncology: Northwestern Memorial Hospital, Chicago, IL
    PGY-2 Medication-Use Safety: Memorial Sloan Kettering Cancer Center, New York, NY
    Precepts: Drug Information & Education

    Current Residents

    Oncology

    Josh Zhang, PharmD
    PGY-1 Pharmacy Residency: The Johns Hopkins Hospital, Baltimore, MD
    Education: Virginia Commonwealth University School of Pharmacy, Richmond, VA

    Lucy Yu, PharmD
    PGY-1 Pharmacy Residency: University of Rochester Medical Center, Rochester, NY
    Education: Northeastern University School of Pharmacy, Boston, MA

    Pain Management/Palliative Care

    Addison Sember, PharmD
    PGY-1 Pharmacy Residency: Phoenix VA Health System, Phoenix, AZ
    Education: University of Findlay College of Pharmacy, Findlay, OH

    Medication-Use Safety and Policy

    Jason Maille, PharmD
    PGY-1 Pharmacy Residency: Indian Health Service, Kotzebue, AK
    Education: Texas A&M College of Pharmacy, College Station, TX

    Past Residents

    Past Residents

    2022-2023

    Oncology

    Niti Patel, PharmD
    PGY-1 Pharmacy Residency: NYU Langone Health, New York, NY
    Education: University of Pittsburgh School of Pharmacy, Pittsburgh, PA
    Current Position: Clinical Pharmacy Specialist – Hospital of the University of Pennsylvania Abramson Cancer Center, Philadelphia, PA

    Sandra Savaya, PharmD
    PGY-1 Pharmacy Residency: St. Joseph's Hospital and Medical Center, Phoenix, AZ
    Education: University of Arizona, Phoenix, AZ
    Current Position: Clinical Pharmacy Specialist, Banner Health System, Phoenix, AZ
     

    Pain Management/Palliative Care

    Allyson Beechy, PharmD
    PGY-1 Pharmacy Residency: VA Connecticut Healthcare System, West Haven, CT
    Education: The Ohio State University College of Pharmacy, Columbus, OH
    Current Position: Clinical Pharmacy Specialist – Palliative Care (Consult Service), Dana-Farber Cancer Institute, Boston, MA
     

    Medication-Use Safety and Policy

    Merihan Raouf, PharmD
    PGY-1 Pharmacy Residency: Lumicera Health Services, Madison, WI
    Education: Albany College of Pharmacy, Albany, NY
    Current Position: Pediatric Clinical Pharmacist – Johns Hopkins All children's Hospital, St. Petersburg, FL
     

    2021-2022

    Oncology

    Omar Marzouk, PharmD
    PGY-1 Pharmacy Residency: Novant Health Presbyterian Medical Center, Charlotte, NC
    Education: University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY
    Current Position: Clinical Pharmacist, Malignant Hematology/Oncology, Fred Hutchinson Cancer Center & Clinical instructor, University of Washington School of Pharmacy, Seattle, WA

    Melinda R. Cook, PharmD
    PGY-1 Pharmacy Residency: Novant Health Presbyterian Medical Center, Charlotte, NC
    Education: University at Michigan College of Pharmacy, Ann Arbor, MI
    Current Position: Bone Marrow Transplant Clinical Pharmacy Specialist, Memorial Sloan Kettering Cancer Center, New York, NY
     

    Pain Management/Palliative Care

    Joseph Ricciutti, PharmD
    PGY-1 Pharmacy Residency: Mount Auburn Hospital, Cambridge, MA
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Clinical Pharmacist Pain Management, Kaweah Health Medical Center, Visalia, CA
     

    Medication-Use Safety

    Nhi Bui, PharmD
    PGY-1 Training: Cox Health Medical Center, Springfield, MO
    Education: The University of Kansas School of Pharmacy, Lawrence, KS
    Current Position: Oncology Clinical Pharmacist, Our Lady of the Lake Regional Medical Center, Baton Rouge, LA
     

    2020-2021

    Oncology

    Shahrier Hossain, PharmD, BCOP
    PGY-1 Pharmacy Residency: Albany Medical Center, Albany, NY
    Education: University at Buffalo: School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY
    Current Position: Clinical Pharmacy Specialist, Myeloma; Dana-Farber Cancer Institute, Boston, MA

    Kristin Markiewicz, PharmD, BCOP
    PGY-1 Pharmacy Residency: Novant Health Presbyterian Medical Center, Charlotte, NC
    Education: University at Buffalo: School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY
    Current Position: Clinical Pharmacy Specialist, Breast/Gyn; Hospital of the University of Pennsylvania – Abramson Cancer Center, Philadelphia, PA
     

    Pain Management/Palliative Care

    Molly Bacon, PharmD
    PGY-1 Pharmacy Residency: University of Pittsburgh Medical Center, Hamot, Erie, PA
    Education: University of South Carolina College of Pharmacy, Columbia, SC
    Current Position: Clinical Pharmacy Specialist-Palliative Care, Dana-Farber Cancer Institute, Boston, MA
     

    Medication-Use Safety

    Angela Chen, PharmD, BCPS
    PGY-1 Pharmacy Residency: Bay Pines VA Healthcare System
    Education: Philadelphia College of Pharmacy
    Current Position: Pharmacist, Children's Specialized Hospital, New Brunswick, NJ
     

    2019-2020

    Oncology

    Eno Inyang, PharmD, BCPS, BCOP
    PGY-1 Pharmacy Residency: St. Joseph Medical Center, Tacoma, Washington
    Education: University of Southern California School of Pharmacy, Los Angeles, CA
    Current Position: Clinical Pharmacy Specialist – Hematopoietic Cell Transplant; Dana-Farber Cancer Institute, Boston, MA

    Shawn Streeter, PharmD, BCOP
    PGY-1 Pharmacy Residency: Riverside University Health System, Moreno Valley, California
    Education: University of North Carolina Eshleman School of Pharmacy, Chapel Hill, NC
    Current Position: Oncology Clinical Pharmacy Specialist – Myeloma/Lymphoma, City of Hope, Duarte, CA
     

    Pain Management/Palliative Care

    Annabelle Hood, PharmD, BCACP
    PGY-1 Pharmacy Residency: University of Charleston School of Pharmacy, Charleston, WV
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Clinical Pharmacy Specialist – Pain Management, Cleveland Clinic, Cleveland, OH
     

    Medication-Use Safety

    Grace Hwang, PharmD, BCOP
    PGY-1 Pharmacy Residency: Houston Methodist Hospital, Houston, Texas
    Education: University of Houston College of Pharmacy, Houston, TX
    Current Position: Clinical Pharmacy Specialist – Leukemia, MD Anderson Cancer Center, Houston, TX
     

    2018-2019

    Oncology

    Megan Duperreault, PharmD, BCOP
    PGY-1 Pharmacy Residency: Brigham and Women's Hospital, Boston, MA
    Education: South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, SC
    Current Position: Clinical Oncology Pharmacist – Hematology, Maine Medical Center, Portland, Maine

    Erin Grannan, PharmD, BCOP
    PGY-1 Pharmacy Residency: MedStar Washington Hospital Center, Washington, DC
    Education: Philadelphia College of Pharmacy at the University of the Sciences, Philadelphia, PA
    Current Position: Clinical Pharmacy Specialist - Medical Breast Oncology, MD Anderson Cancer Center, Houston, TX
     

    Pain Management/Palliative Care

    Mara Hofherr, PharmD
    PGY-1 Pharmacy Residency: Christian Hospital, St. Louis, MO
    Education: Saint Louis College of Pharmacy, St. Louis, MO
    Current Position: Oncology Pharmacy Specialist – Palliative Care, Washington University Center for Advanced Medicine, St. Louis, MO
     

    Medication-Use Safety

    Garrett Rompelman, PharmD
    PGY-1 Pharmacy Residency: Community Healthcare System - Community Hospital, Munster, IN
    Education: University of Illinois at Chicago College of Pharmacy, Chicago, IL
    Current Position: Clinical Infusion Pharmacist, Dana- Farber Cancer Institute, Boston, MA
     

    2017-2018

    Oncology

    Elaine Xiang, PharmD, BCOP     
    PGY-1 Pharmacy Residency: NYU Langone Medical Center, New York, NY     
    Education: Northeastern University School of Pharmacy, Boston, MA
    Current Position: Clinical Pharmacotherapy Specialist - Hematology/Oncology, New York University Langone Health, New York, NY

    Patrick McBride, PharmD, BCOP
    PGY-1 Pharmacy Residency: Children's Hospital of Wisconsin, Milwaukee, WI     
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA     
    Current Position: Pediatric Oncology Clinical Pharmacist, Dana-Farber Cancer Institute, Boston, MA
     

    Pain Management/Palliative Care

    Iman F. Suliman, PharmD
    PGY-1 Pharmacy Residency: North Florida/South Georgia Veterans Health System    
    Education: University of Florida College of Pharmacy, Gainesville, FL     
    Current Position: Clinical Education Pharmacist, Dana-Farber Cancer Institute, Boston, MA
     

    2016-2017

    Oncology

    Huong (Heather) Truong, PharmD, BCOP     
    PGY-1 Pharmacy Residency: Yale New Haven Health system, New Haven, CT    
    Education: University of Connecticut School of Pharmacy, Storrs, CT
    Current Position: Hematology/Oncology Pharmacist, Mayo Clinic, Rochester, MN

    Mary Nauffal, PharmD, MS, BCOP     
    PGY-1 Pharmacy Residency: Brigham and Women's Hospital, Boston, MA     
    Education: Lebanese American University, Beirut, Lebanon     
    Current Position: Clinical Pharmacy Specialist – Bone Marrow Transplant, Memorial Sloan Kettering, New York, NY
     

    Pain Management/Palliative Care

    Benjamin S. Kematick, PharmD, BCACP
    PGY-1 Pharmacy Residency: University at Buffalo/Mobile Pharmacy Solutions, Buffalo, NY
    Education: University at Buffalo School of Pharmacy, Buffalo, NY
    Current Position: Clinical Pharmacy Specialist - Palliative Care, Dana-Farber Cancer Institute, Boston, MA
     

    2015-2016

    Oncology

    Jacob Barker, PharmD
    PGY-1 Pharmacy Residency: University of Michigan Health System, Ann Arbor, MI
    Education: University of New England School of Pharmacy, Portland, ME
    Current Position: Oncology Pharmacist Clinician, University of Vermont Medical Center, Burlington, VT

    Sydney Smith, PharmD, BCOP
    PGY-1 Pharmacy Residency: Cleveland Clinic, Cleveland, OH
    Education: Rosman University of Health Sciences, Henderson, NV
    Current Position: Clinical Pharmacy Specialist, Breast Oncology, Dana-Farber Cancer Institute, Boston, MA
     

    2014-2015

    Oncology

    Doug Hackenyos, PharmD, BCOP     
    PGY-1 Pharmacy Residency: Tufts Medical Center, Boston, MA
    Education: Massachusetts College of Pharmacy and Health Sciences, Worcester, MA
    Current Position: Oncology Pharmacy Clinical Coordinator, UConn Health, Farmington, CT

    Cynthia Herrera, PharmD, BCPS, BCOP     
    PGY-1 Pharmacy Residency: Northwestern Memorial Hospital, Chicago, IL
    Education: Purdue University College of Pharmacy, West Lafayette, IN
    Current Position: Medical Science Liaison, Bristol Myers Squibb, Washington, DC
     

    2013-2014

    Oncology

    Laura (Perry) Hackett, PharmD, BCOP     
    PGY-1 Pharmacy Residency: Dartmouth-Hitchcock Medical Center, Lebanon, NH
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Clinical Pharmacist Lead, Medical Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH

    Taylor Butler, PharmD, BCOP     
    PGY-1 Pharmacy Residency: Blount Memorial Hospital, Maryville, TN
    Education: University of Tennessee Health Science Center, Memphis and Knoxville, TN
    Current Position: Palliative Care Clinical Pharmacy Specialist, Vanderbilt University Medical Center, Nashville, TN
     

    2012-2013

    Oncology

    Amanda Dietzek, PharmD, BCOP
    PGY-1 Pharmacy Residency: Einstein Medical Center, Philadelphia, PA
    Education: Northeastern University School of Pharmacy, Boston, MA
    Current Position: Oncology Clinical Pharmacy Manager, Einstein at Center One Pharmacy, Philadelphia, PA

    Kelly Connelly, PharmD, BCOP     
    PGY-1 Pharmacy Residency: Mount Sinai Medical Center, New York, NY
    Education: Duquesne University, Mylan School of Pharmacy, Pittsburgh, PA
    Current Position: Clinical Pharmacy Specialist, Johns Hopkins Hospital, Baltimore, MD
     

    2011-2012

    Oncology

    Kelley Carlstrom, PharmD, BCOP
    PGY-1 Pharmacy Residency: Beth Israel Deaconess Medical Center, Boston, MA
    Education: University of Colorado, Denver College of Pharmacy, Denver, CO
    Current Position: Clinical Oncology Content Specialist, Project Ronin; CEO/Founder, KelleyCPharmD, LLC
     

    2010-2011

    Oncology

    Meredith W. H. Higley, PharmD, BCPS, BCOP
    PGY-1 Pharmacy Residency: Parkview Health, Fort Wayne, IN
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Coordinator, Oncology Pharmacy Services, Berkshire Medical Center, Pittsfield, MA
     

    2009-2010

    Oncology

    Houry Leblebjian, PharmD, BCOP
    PGY-1 Pharmacy Residency: UMass Memorial Medical Center, Worcester, MA
    Education: Lebanese American University, West Beirut, Lebanon
    Current Position: Clinical Pharmacy Manager, Dana-Farber Cancer Institute, Boston, MA
     

    2008-2009

    Oncology

    Jian Ni, PharmD, MPH, BCOP
    PGY-1 Pharmacy Residency: West Virginia University Hospital, Morgantown, WV
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
    Current Position: Hematology/Oncology Pharmacy Specialist, Brigham and Women's Hospital, Boston, MA
     

    2007-2008

    Oncology

    Delila Katz, PharmD, BCOP
    PGY-1 Pharmacy Residency: Boston Medical Center, Boston, MA
    Current Position: Clinical Pharmacy Specialist – Palliative Care Oncology, UMass Memorial Medical Center, Worcester, MA
     

    2006-2007

    Oncology

    Victor Phantumvanit, PharmD, BCPS, BCOP
    PGY-1 Pharmacy Residency: Central Washington Hospital, Wenatchee, WA
    Education: University of Maryland School of Pharmacy, Baltimore, MD
    Current Position: Clinical Pharmacy Specialist – Palliative Care, Dana-Farber Cancer Institute, Boston, MA
     

    2005-2006

    Oncology

    Gayle Blouin, PharmD, BCOP
    Education: Northeastern University (BS Pharmacy), Massachusetts College of Pharmacy and Health Sciences (PharmD), Boston, MA
    Current Position: Clinical Pharmacy Manager - Chestnut Hill and satellites, Dana-Farber Cancer Institute, Boston, MA